Pharmaceutical companies are under intense pressure to cut costs while delivering the latest drugs and therapies to the global market at unprecedented speeds. How can you find efficiencies without sacrificing quality, adhere to the changing regulatory environment and protect global health outcomes? he answer lies in tapping the value of data.